NEW YORK (GenomeWeb News) – Microfluidics firm Dolomite today said it has licensed microdroplet generation technology IP from the Japan Science and Technology Agency.

The deal covers patent families WO2002/068104 and WO2005/089921, and as part of the agreement, Dolomite can sublicense the technology. Licenses are issued on a per-chip basis and are available in any quantity. Dolomite customers can purchase and use Dolomite droplet chips for R&D.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.